MK

Mohan Krishna Adabala

Active Director Managing Director DIN 00874294
DIN 00874294 First appointment Nov 2006 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 3 historical roles
Total affiliations 5 Since Nov 2006
Shareholding value •••• Premium profile

About Mohan Krishna Adabala

Data last updated:

Mohan Krishna Adabala is a Managing Director at Medchem Organics Private Limited (since 2007) and Director at Emkay Finind Services India Private Limited (since 2014). The companies operate in Pharma and Insurance. The 2 current companies with reported revenue have a combined latest revenue of ₹13 Lakh; the largest is Medchem Organics Private Limited at ₹7 Lakh (FY 2025). Earlier, Mohan Krishna Adabala was a Director at Vision Drugs Private Limited (2007–2012) and Director at Mahalakshmi Laboratories Private Limited (2006–2011) and 1 more.

DIN 00874294
Primary Designation Managing Director
Industry Pharma
First Appointment 16 Nov 2006
Oldest Company Age 19 yrs
Largest company Medchem Organics Private Limited · ₹7 Lakh (FY 2025)
Combined revenue ₹13 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medchem Organics Private Limited U24110TG2007PTC053487
Managing Director09 Apr 20072007₹7 Lakh (FY 2025)Active
Director14 Feb 20142014₹6 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vision Drugs Private Limited U99999TG2005PTC048204
Director12 Feb 20072005₹160 Cr (FY 2024)Active
Director16 Nov 20062006₹33.56 Cr (FY 2025)Active
Medchem Pharma Private Limited U24100TG2016PTC103423
Managing Director22 Feb 20162016₹1.5 Lakh (FY 2017)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medchem Pharma Private Limited
Medchem Organics Private Limited
Emkay Finind Services India Private Limited
Vision Drugs Private Limited
Premium access

Shareholding and investment profile for Mohan Krishna Adabala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohan Krishna Adabala

Mohan Krishna Adabala currently holds 2 directorships: Medchem Organics Private Limited (Managing Director, since 09 Apr 2007, revenue ₹7 Lakh (FY 2025)); Emkay Finind Services India Private Limited (Director, since 14 Feb 2014, revenue ₹6 Lakh (FY 2025)).

Mohan Krishna Adabala was first appointed on 16 Nov 2006 as Director at Mahalakshmi Laboratories Private Limited. The most recent appointment on record is 22 Feb 2016 at Medchem Pharma Private Limited.

The 2 current companies of Mohan Krishna Adabala that report revenue have a combined latest revenue of ₹13 Lakh: Medchem Organics Private Limited ₹7 Lakh (FY 2025); Emkay Finind Services India Private Limited ₹6 Lakh (FY 2025).

Mohan Krishna Adabala held 3 earlier board appointments: Vision Drugs Private Limited (Director, 12 Feb 2007 to 06 Aug 2012); Mahalakshmi Laboratories Private Limited (Director, 16 Nov 2006 to 06 Oct 2011); Medchem Pharma Private Limited (Managing Director, from 22 Feb 2016).

The current boards of Mohan Krishna Adabala's companies include Venkateswara Rao Ganesula (Medchem Organics Private Limited), Adabala Naresh (Emkay Finind Services India Private Limited), Atanu Goswami (Emkay Finind Services India Private Limited), Chandra Prakash Mukka (Emkay Finind Services India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available